Utama › Leukemia Mieloid Akut › South Carolina

Kajian klinikal Leukemia Mieloid Akut di South Carolina

16 kajian untuk Leukemia Mieloid Akut sedang mencari peserta di lokasi di South Carolina.

Bandar di South Carolina

Teks kajian rasmi (Bahasa Inggeris)

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

AnMed Health Cancer Center, Anderson
Prisma Health Richland Hospital, Columbia
McLeod Regional Medical Center, Florence
dan 12 lagi

Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan

Umur 40 hingga 75 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05334069

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

Prisma Health Cancer Institute - Spartanburg, Boiling Springs
Prisma Health Cancer Institute - Easley, Easley
Prisma Health Cancer Institute - Butternut, Greenville
dan 4 lagi

Mengambil pesertaFasa 2

Umur 18 hingga 59 · Semua jantina · Dikemas kini 28 Sep 2026 · NCT05554393

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Prisma Health Cancer Institute - Spartanburg, Boiling Springs
Medical University of South Carolina, Charleston
Prisma Health Cancer Institute - Easley, Easley
dan 5 lagi

Mengambil pesertaFasa 2

Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT05564390

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

Prisma Health Cancer Institute - Spartanburg, Boiling Springs
Medical University of South Carolina, Charleston
Prisma Health Cancer Institute - Easley, Easley
dan 5 lagi

Mengambil pesertaFasa 2

Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT06317649

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Prisma Health Cancer Institute - Spartanburg, Boiling Springs
Prisma Health Cancer Institute - Easley, Easley
Prisma Health Cancer Institute - Butternut, Greenville
dan 4 lagi

Mengambil pesertaFasa 2

Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT06672146

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Prisma Health Cancer Institute - Spartanburg, Boiling Springs
Medical University of South Carolina, Charleston
Prisma Health Cancer Institute - Easley, Easley
dan 5 lagi

Mengambil pesertaFasa 2

Umur 18 hingga 59 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT05554406

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Medical University of South Carolina, Charleston
Prisma Health Richland Hospital, Columbia
BI-LO Charities Children's Cancer Center, Greenville

Mengambil pesertaFasa 3

6 Months – 21 Years · Semua jantina · Dikemas kini 17 Sep 2026 · NCT04293562

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

MUSC Health University Medical Center, Charleston

Mengambil pesertaFasa 2

Umur 18 ke atas · Semua jantina · Dikemas kini 15 Sep 2026 · NCT04996875

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

Bon Secours St. Francis Cancer Center, Greenville

Mengambil pesertaFasa 1/2

Umur 12 ke atas · Semua jantina · Dikemas kini 3 Sep 2026 · NCT04588922

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Medical University of South Carolina, Charleston
Prisma Health Richland Hospital, Columbia
BI-LO Charities Children's Cancer Center, Greenville

Mengambil pesertaFasa 1/2

Sehingga umur 22 · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT04726241

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

Prisma Health Richland Hospital, Columbia

Mengambil pesertaFasa 3

29 Days – 21 Years · Semua jantina · Dikemas kini 24 Ogo 2026 · NCT05183035

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Prisma Health, Greenville

Mengambil pesertaFasa 1

Umur 18 ke atas · Semua jantina · Dikemas kini 20 Ogo 2026 · NCT06001788

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Medical University of South Carolina, Charleston

Mengambil pesertaKajian pemerhatian

Semua umur · Semua jantina · Dikemas kini 6 Jul 2026 · NCT01351545

Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation

Medical University of South Carolina, Charleston

Mengambil pesertaFasa 1

Umur 18 ke atas · Semua jantina · Dikemas kini 15 Jun 2026 · NCT02074839

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

Hollings Cancer Center, Charleston

Mengambil pesertaFasa 2/3

Umur 18 ke atas · Semua jantina · Dikemas kini 30 Apr 2026 · NCT04256317

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

Medical University of South Carolina, Charleston

Mengambil pesertaFasa 1/2

Umur 12 ke atas · Semua jantina · Dikemas kini 24 Mac 2026 · NCT04988555

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.